Login

Empowering Independent Agents In Insurtech|Adam Blumencranz,Partner,Distributed Ventures 00:10:00

Share On Facebook Share On Twitter

oversees deal execution, board representation and general fund management. have a deep understanding of the Property and Casualty insurance industry that allows me to provide significant insights and value to our Insurtech portfolio companies.

Recent Videos

00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

00:10:00
Navigating Commercial Real Estate Trends and Technology Integration| Peter M. Mavoides, CEO ,Essential Properties Realty Trust Inc.
00:10:00
Raising Money Isn't A Measurement Of Success|Robb Doub,General Partner,New Markets Venture Partners
00:10:00
Wojciech Szwarc: Benefit Systems Sales Dynamics Exceed Expectations | Wojciech Szwarc - Management Board Member at Benefit Systems S.A.
00:10:00
DOTD CEO Milan Patel and CFO Paraag Amin provide an overview of the company's full-year results for the period ending June 30, 2021, highlighting key operational achievements and financial performance, and outlining future focus areas​|Milan Patel, CEO of
00:10:00
Owl Ventures is the largest venture capital firm in the world focused on the education technology market|Tory Patterson,Co-Founder, Managing Director,Owl Ventures
00:10:00
Ankhor Gold's Investment and Development in Cambodia: An Overview
00:10:00
The Oil Shock' to discuss the current state of U.S. oil and gas infrastructure|Alan Armstrong, CEO of Williams Companies
00:10:00
Keith Muller, CEO of Atlantic Lithium, Discusses Ewoyaa Project and Future Plans
00:10:00
Navigating the Future of Financial Planning with Dr. Martin Seay, Ph.D., CFP®
00:10:00
we are passionate about helping our clients to succeed|Mounir Guen,Chief Executive Officer, MVision Private Equity Advisers USA LLC
00:10:00
Macron's Victory: Impact on French Business and Talent Retention | Christophe Bavière, CEO, Idinvest Partners.
00:10:00
Treatment of cancer in dogs and neurodegenerative diseases in humans.|Dr Michael Thurn,Chief Executive Officer,PharmAust Ltd

© 2017 - Townhall + Tv